Topic Archives: TransAct Technologies (TACT)

Comments

  • Thanks Travis! Wow............. awesome analysis on the vague clues there. The subscription price seems a bit high (No ...

  • high velocity optios seems to be good concept.it was used by paul tudor jones(with 200ma). you take stock in strong uptr...

  • Hello Diane, Thank you for your feedback and engagement within our services. It is always nice to see our members pu...

  • I wouldn't bet against China blocking online cryptocurrencies IF they decide that's a real priority -- and if you block ...

  • Reds: The rule was made so that we all transact as equals here. The info/opinion provided by someone with 10 shares can ...

  • Blackngold: Like others, I welcome you here. I thought it worth adding a few lines to what's been said, not to attack or...

  • Lulu and all: Oh its certainly NOT the size of any 'gift' that matters. We have worked hard on SG to make it a ' wealth ...

  • $MRUS np - The second company is Merus, a bispecific antibody play. Remember that IgG monoclonals are like a two-pronged...

  • I'm aware of two biotech IPOs that warrant some comment. One, despite the vexing environment, I am glad to see companies...

  • Yes, the lack of something more formal re: takeover is disquieting. We should soon be getting some early sales data, tho...

  • Scorpio: What I don't understand is how these 9 mil shares are to be factored in to the float. Clearly, your assumptions...

  • Sharon, I know little then what I have learned here with other gummies.....I read all 100 plus emails a day but And stil...

  • This is absolute nonsense. Here are the fatal flaws: 1. So-called cherry-pickers have been wise to this for many y...

  • CVRR and ALDW are my favorites. Be prepared to sell though. Crack spread could easily halve, dividend halve, and stock p...

  • With all these investment letters touting foreign stocks I have a basic investment question. Does it complicate income t...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info